CN Patent

CN112955130A — 包含取代茚满的固体分散体和药物组合物及其制备和使用方法

Assigned to Peloton Therapeutics Inc · Expires 2021-06-11 · 5y expired

What this patent protects

本文提供了包含HIF‑2α抑制剂的固体分散体、包含所述固体分散体的药物组合物和治疗HIF‑2α‑介导的疾病和病况的方法。

USPTO Abstract

本文提供了包含HIF‑2α抑制剂的固体分散体、包含所述固体分散体的药物组合物和治疗HIF‑2α‑介导的疾病和病况的方法。

Drugs covered by this patent

Patent Metadata

Patent number
CN112955130A
Jurisdiction
CN
Classification
—
Expires
2021-06-11
Drug substance claim
No
Drug product claim
No
Assignee
Peloton Therapeutics Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.